0%
0%
0%
0%
0%
About Tonix Pharmaceuticals Holding Corp
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Seth Lederman
Website
tonixpharma.com
Headquarters
Chatham
Employees
117
Founded
2007
ISIN
US8902608541
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.
TNXP - Bullish alongside SIGAWe may see some movement on this one in the coming weeks just like SIGA. I have drawn out 2 levels of resistance with interest on my end after a clean break of $2.00. I will be watching for a technical setup in the coming days to decide whether or not I will take a position. (Not Financial Advice) T
TNXP (Request counter) Requested Analysis
Resistance at 3.02 and 4.75. Generally, I would not recommend this kind of chart and industry. The biotech industry tends to have a very volatile nature. It is usually driven by news/rumors. Extremely hard to predict. If you're lucky, you may get a 20-30% rally price due to some
TNXP Tonix Pharmaceuticals produces the Monkeypox Vaccine ! Tonix is a producer of the TNX-801 vaccine, effective against Smallpox and Monkeypox.
But that`s not all!
They have a strong balance sheet, Cash and Cash Equivalents Totaled Approximately $140 Million VS its mk cap of only $44.03Mil.
Seth Lederman, M.D., Chief Executive Officer of Tonix: “Tonix
TNXP - Bullish?I like how price is shaping up (higher high and higher lows).
The oscillators I like are all finally headed in the right direction (green MACD histogram and line about to cross above 0 is good to see).
RSI is above 50, which is another good sign.
It's early days, but TNXP may have found the bottom
TNXP - A Chance To Get OutYesterdays bounce with gap is almost certainly a short covering rally at phi relation taken from 3 significant pivots.
It essentially provides buyers with a short window to get out with a small amount of grace.
Most likely service will be resumed to the downside and that gap will fill.
That said
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
